Carboxylic acid salts
TARGETMOL CHEMICALS INC ETOMOXIR SODIUM SALT 25MG
Also available in 5 mg 10 mg 50 mg 100 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. (R)-Etomoxir sodium salt ((R)-Etomoxir sodium salt) is R-form of Etomoxir. Etomoxir is a potent inhibitor of carnitine palmitoyltransferase-I (CPT-1). purity: 99%
Pfanstiehl Inc Sodium Succinate Hexahydrate, High Purity, Low Endotoxin, Low Metals USP-NF, JPE (D-161) 5kg pack GMP, Multi-compendial CAS: 6106-21-4 Injectable Excipient Grade
Pfanstiehl Sodium Succinate (Hexahydrate) High Purity, Low Endotoxin, Low Metals is a multi-compendial fully hydrated form of Na succinate that has been specifically designed and formulated to remove impurities such as endotoxin, trace metals, and nitrosamines. Manufactured in the USA under ICH-Q7 cGMP conditions, Pfanstiehl Sodium Succinate meets parenteral (injectable) excipient grade standards, making it ideal for pharmaceutical, biologic, and vaccine bioprocessing and formulation. Pfanstiehl Brand Sodium Succinate (Anhydrous) is compliant with the USP monograph established in 2017 and available as USP-NF (United States Pharmacopoeia National Formulary) and JP (Japanese Pharmacopoeia) Compendial, U.S.P. , cGMP , pharmaceutical grade .
Strem, An Ascensus Company CAS# 41575-94-4. 250mg. 1,1-Cyclobutanedicarboxylatodiammineplatinum(II), 99% CARBOPLATIN. MFCD00070464
CAS# 41575-94-4. 250mg. 1,1-Cyclobutanedicarboxylatodiammineplatinum(II), 99% CARBOPLATIN. MFCD00070464. Molecular Weight: 371.26. Molecular Formula: C6H12N2O4Pt. Color/form: white xtl. Strem# 78-0255. http://www.strem.com/catalog/v/78-0255/
eMolecules Octyl formate | 112-32-3 | MFCD00046147 | 25g
Oakwood Chemicals | Octyl formate | 25g | 508866133 | 102669 | | 112-32-3 | MFCD00046147 | 158.241 | C9H18O2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Sigma Aldrich Fine Chemicals Biosciences Disodium succinate >=98% | 150-90-3 | MFCD00002790 | 10KG
Disodium succinate >=98% | Purity: >=98% | Mol Wt: 162.05 | 150-90-3 | MFCD00002790 | 10KG
Medchemexpress LLC Tasurgratinib succinate | 1879965-80-6 | 99.2% | 764.82 g·mol⁻¹ | C32H37N5O6 · 3/2 C4H6O4 | 5 MG
Tasurgratinib succinate is the succinate salt of an orally active, selective inhibitor of FGFR1-3 used in preclinical and research applications. The compound shows low-nanomolar potency against FGFR1, FGFR2, and FGFR3 and is supplied as a high-purity solid or as a DMSO solution for laboratory studies.
- High purity suitable for research use.
- Potent FGFR1/2/3 inhibition at low nanomolar concentrations.
- Available as solid and as DMSO solution for assay flexibility.
- Soluble in DMSO at high concentration (≈100 mg/mL).
- Pack sizes appropriate for preclinical experiments.
Medchemexpress LLC Suramin sodium salt | 129-46-4 | 100.0% | 10 MG
Suramin sodium salt is the hexasodium salt of suramin provided for research use as a reversible and competitive protein-tyrosine phosphatase inhibitor. It is offered as a high-purity solid with documented solubility in DMSO and water and defined storage recommendations for both solid and solution states.
- High purity solid (99.98%).
- Soluble in DMSO and water (50 mg/mL; may require ultrasonic or warming).
- Supplied as a 10 mg package suitable for small-scale studies.
- Intended for enzyme inhibition and pharmacology research applications.
- Store solid at 4°C; in solvent, store at -80°C (6 months) or -20°C (1 month).
Chem-Impex International, Inc. Sodium maleate dibasic anhydrous | MFCD00013059 | 100G
Sodium maleate dibasic anhydrous, MFCD00013059, 100G
Apexbio Technology LLC CL 316243 disodium salt 151126-84-0 1mg
CL 316243 disodium salt is a small-molecule agonist targeting the 3-adrenergic receptor It is designed to activate 3 receptors thereby modulating lipolytic and thermogenic pathways predominantly in adipose tissues CL 316243 disodium salt exerts its biological activity by selectively binding to 3-adrenergic receptors leading to enhanced adipocyte-mediated lipid metabolism In experimental rodent models administration of CL 316243 increases insulin sensitivity and reduces obesity-related hyperglycemia by promoting glucose uptake primarily in adipose tissue Based on these pharmacological properties CL 316243 disodium salt holds research potential in the study of 3 receptor-mediated metabolic mechanisms and the exploration of therapeutic strategies for metabolic disorders such as obesity and type 2 diabetes
eMolecules Ambeed / 2-Hydroxy-NNN-trimethylethan-1-aminium 34-dicarboxy-3-hydroxybutanoate / 25g / 525096920 / A179663 / / 77-91-8 / MFCD00038734 / 295.288 / C11H21NO8
Ambeed / 2-Hydroxy-NNN-trimethylethan-1-aminium 34-dicarboxy-3-hydroxybutanoate / 25g / 525096920 / A179663 / / 77-91-8 / MFCD00038734 / 295.288 / C11H21NO8
TARGETMOL CHEMICALS INC FOSTAMATINIB DISODIUM 10MG
Also available in 1 mg 2 mg 5 mg 25 mg 50 mg 100 mg 500 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Fostamatinib Disodium (R788 Disodium) is an orally available Syk kinase inhibitor with potential anti-inflammatory and immunomodulating activities. purity: 98%
Apexbio Technology LLC Cefotaxime (sodium salt)(Synonyms: Claforan, Cefotaxime Sodium, Cefotaxim sodium salt, Cefotaxime Na, Sodium cefotaxime), 1g, CAS: 64485-93-4.
Cefotaxime sodium (CAS 64485-93-4) is a third-generation cephalosporin antibiotic belonging to the -lactam group characterized by inhibition of bacterial cell-wall synthesis through binding to penicillin-binding proteins In vitro analyses show strong inhibitory efficacy against various bacterial species notably cefotaxime exhibits an MIC below 0 1 g/ml against Streptococcus pneumoniae It also demonstrates high activity against Haemophilus influenzae including -lactamase-producing strains In vivo mouse model studies revealed that combination therapy of cefotaxime with minocycline enhanced survival following Vibrio vulnificus infection compared to single-agent treatments Clinically cefotaxime has been evaluated in pneumonia therapy demonstrating good tolerance and therapeutic utility in targeting susceptible bacterial pathogens